These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17119927)

  • 21. Open channel block of Kv1.5 currents by citalopram.
    Lee HM; Hahn SJ; Choi BH
    Acta Pharmacol Sin; 2010 Apr; 31(4):429-35. PubMed ID: 20228830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
    Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoxetine blocks cloned neuronal A-type K+ channels Kv1.4.
    Choi BH; Choi JS; Ahn HS; Kim MJ; Rhie DJ; Yoon SH; Min DS; Jo YH; Kim MS; Hahn SJ
    Neuroreport; 2003 Dec; 14(18):2451-5. PubMed ID: 14663209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of Kv1.5 channels by the antidepressant drug sertraline.
    Lee HM; Hahn SJ; Choi BH
    Korean J Physiol Pharmacol; 2016 Mar; 20(2):193-200. PubMed ID: 26937216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Kv1.3 channels by H-89 (N--[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide) independent of protein kinase A.
    Choi J; Choi BH; Hahn SJ; Yoon SH; Min DS; Jo Y; Kim M
    Biochem Pharmacol; 2001 Apr; 61(8):1029-32. PubMed ID: 11286994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and molecular basis for the block of Kv1.3 channels induced by carvedilol in HEK293 cells.
    Yang JF; Cheng N; Ren S; Liu XM; Li XT
    Eur J Pharmacol; 2018 Sep; 834():206-212. PubMed ID: 30016664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open channel block of Kv3.1 currents by fluoxetine.
    Sung MJ; Ahn HS; Hahn SJ; Choi BH
    J Pharmacol Sci; 2008 Jan; 106(1):38-45. PubMed ID: 18187934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of Kv1.5 by paroxetine, an antidepressant drug.
    Lee HM; Hahn SJ; Choi BH
    Korean J Physiol Pharmacol; 2016 Jan; 20(1):75-82. PubMed ID: 26807026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of psoralen on the cloned Kv3.1 currents.
    Sung MJ; Hahn SJ; Choi BH
    Arch Pharm Res; 2009 Mar; 32(3):407-12. PubMed ID: 19387585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory actions of the phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel.
    Wu J; Ding WG; Matsuura H; Tsuji K; Zang WJ; Horie M
    Br J Pharmacol; 2009 Jan; 156(2):377-87. PubMed ID: 19154427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
    Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade action of ketanserin and increasing effect of potassium ion on Kv1.3 channels expressed in Xenopus oocytes.
    Wang X; Liao Y; Zou A; Li L; Tu D
    Pharmacol Res; 2007 Aug; 56(2):148-54. PubMed ID: 17582781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of (-)-epigallocatechin-3-gallate, the main component of green tea, on the cloned rat brain Kv1.5 potassium channels.
    Choi BH; Choi JS; Min DS; Yoon SH; Rhie DJ; Jo YH; Kim MS; Hahn SJ
    Biochem Pharmacol; 2001 Sep; 62(5):527-35. PubMed ID: 11585049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay.
    Liu K; Samuel M; Tillett J; Hennan JK; Mekonnen B; Soloveva V; Harrison RK; Paslay JW; Larocque J
    J Biomol Screen; 2010 Feb; 15(2):185-95. PubMed ID: 20044579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Block of cloned Kv4.3 potassium channels by dapoxetine.
    Jeong I; Kim SW; Yoon SH; Hahn SJ
    Neuropharmacology; 2012 Jun; 62(7):2261-6. PubMed ID: 22192593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells.
    Fu XX; Du LL; Zhao N; Dong Q; Liao YH; Du YM
    J Ethnopharmacol; 2013 Jul; 148(2):647-54. PubMed ID: 23707333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels.
    Punke MA; Friederich P
    Anesth Analg; 2007 May; 104(5):1256-64, tables of contents. PubMed ID: 17456683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of human HERG K⁺ channels by rosiglitazone, an antidiabetic drug.
    Lee SH; Sung MJ; Hahn SJ; Kim J; Min G; Jo SH; Choe H; Choi BH
    Arch Pharm Res; 2012 Sep; 35(9):1655-64. PubMed ID: 23054723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells.
    Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR
    Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
    Arias C; Guizy M; David M; Marzian S; González T; Decher N; Valenzuela C
    Anesthesiology; 2007 Oct; 107(4):641-51. PubMed ID: 17893461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.